News for 'Health Management and Research Institute'

CAs scramble to fathom new whistleblowing law

CAs scramble to fathom new whistleblowing law

Rediff.com2 Nov 2021

Chartered accountants are readying themselves for a higher onus on individuals to report violations that they come across as part of their work. There has been a scramble to understand the implications as the non-compliance with laws and regulations (NOCLAR) comes into effect in less than six months. It is applicable from April 1, 2022 after being deferred earlier because of the Covid-19 pandemic.

Jameel announced resignation in meeting of INSACOG, left colleagues surprised

Jameel announced resignation in meeting of INSACOG, left colleagues surprised

Rediff.com17 May 2021

Scientists associated with Indian SARS-CoV-2 Consortium on Genomics (INSACOG), the government panel that conducts research on different variants of the coronavirus, said they were surprised at noted virologist Shahid Jameel's decision to quit the group and wondered whether he was disillusioned with the government's handling of the pandemic.

Don't mock India's scientific past!

Don't mock India's scientific past!

Rediff.com27 Feb 2020

It is important to approach the belief of people in ancient India's achievements with a sense of proportion, balance and empathy, argues B S Raghavan, the distinguished civil servant.

Govt issues advisory for rational use of Remdesivir

Govt issues advisory for rational use of Remdesivir

Rediff.com7 Jun 2021

The government on Monday issued an advisory for rational use of Remdesivir in COVID-19 treatment, underlining that the anti-viral drug must be advised by senior faculty members directly involved in the patient's care.

India's children may get 2 Covid vaccines by December

India's children may get 2 Covid vaccines by December

Rediff.com28 Jun 2021

While Bharat Biotech's Covaxin is in trials among children already, Serum Institute of India will begin Novavax vaccine trials on children from July, whereas the Pfizer vaccine has been approved for adolescents in the United States; and Cadila Healthcare's ZyCoV-D has done trials on 12 year-olds and above already, reports Sohini Das.

India's first COVID-19 vaccine gets nod for human trials

India's first COVID-19 vaccine gets nod for human trials

Rediff.com30 Jun 2020

COVAXIN, developed by Hyderabad-based Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, has got the nod for human clinical trials from the Drug Controller General of India

India Sitting on COVID Time Bomb

India Sitting on COVID Time Bomb

Rediff.com12 Aug 2021

Whether the third wave will ravage us depends on the pace of vaccinations, careful and calibrated opening up of establishments, and a strategy to contain the spread in specific states or pockets.

Govt fast-tracks approval for foreign-produced COVID vaccines

Govt fast-tracks approval for foreign-produced COVID vaccines

Rediff.com13 Apr 2021

The first 100 beneficiaries of such foreign vaccines shall be assessed for seven days for safety outcomes before it is rolled out for further immunisation programme within the country, the Union health ministry said.

Vaccine trials: Bharat Biotech recruits 23,000 volunteers

Vaccine trials: Bharat Biotech recruits 23,000 volunteers

Rediff.com3 Jan 2021

Covaxin is being developed by Bharat Biotech jointly with the Indian Council of Medical Research (ICMR)- National Institute of Virology (NIV). The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers and it is the country's first and only Phase III efficacy study for a COVID-19 vaccine, a press release from the vaccine maker said on Saturday night.

The Pension Challenge Confronting India

The Pension Challenge Confronting India

Rediff.com18 Apr 2022

When we look at the pension expenditure of the states, so far, there has been no gain from the NPS reform. Pension expenses as a share of total state revenue expenditure rose from 4% in 1991-1992 to 10% at the time of the NPS reform, and have risen further to about 12%, observes Ajay Shah.

Beam me up, Scotty! Indian tech firm helped in Wuhan's Covid-19 fight

Beam me up, Scotty! Indian tech firm helped in Wuhan's Covid-19 fight

Rediff.com30 Mar 2020

Thanks to technological support provided by BlinkIN, a Bengaluru-based intelligent visual-assistance company, engineers in Wuhan were able to remotely install air ventilation systems in two hospitals in Wuhan, the epicentre of the coronavirus pandemic, reports Peerzada Abrar.

MPs will need COVID negative report for Parliament

MPs will need COVID negative report for Parliament

Rediff.com4 Sep 2020

The COVID-19 test of the MPs need to be done 72 hours before the start of the session and it can be done either in their constituencies or at the Parliament complex.

India reports 6 cases of UK coronavirus strain

India reports 6 cases of UK coronavirus strain

Rediff.com29 Dec 2020

All these persons have been kept in single room isolation at designated health care facilities by respective state governments and their close contacts have also been put under quarantine, the ministry said.

10 foods that are good for your GUT

10 foods that are good for your GUT

Rediff.com8 Nov 2019

Green vegetables contain a high amount of soluble and insoluble fiber to balance your good and bad gut bacteria.

ASK MAYANK: I've a new job offer, should I take it?

ASK MAYANK: I've a new job offer, should I take it?

Rediff.com7 Apr 2021

How do you decide if you should take up a new job in these difficult times? HR guru Mayank Rautela has some tips that could help you decide.

We must vaccinate 140 million people a month!

We must vaccinate 140 million people a month!

Rediff.com26 Feb 2021

At 8 million a month, times two doses, it will take us 17 years to administer the vaccine to our 800 million adults. The rollout must speed up twenty times, asserts Naushad Forbes.

Modiji, we are going to die: A Bihar nurse's terrified plea

Modiji, we are going to die: A Bihar nurse's terrified plea

Rediff.com30 Mar 2020

A staff nurse from a Bihar hospital begs the prime minister for her life as the state's medical staff continues to treat suspected COVID-19 patients without protective safety kits.

Girl dies of dengue, parents billed Rs 18 lakh by Fortis; probe ordered

Girl dies of dengue, parents billed Rs 18 lakh by Fortis; probe ordered

Rediff.com21 Nov 2017

Health Minister J P Nadda asked for all details in the matter and promised that all necessary action would be taken.

No better time to be young than now: PM at Bhutan varsity

No better time to be young than now: PM at Bhutan varsity

Rediff.com18 Aug 2019

Addressing the students of the Royal University of Bhutan in Thimphu, Modi asked them to work hard and take the Himalayan nation to great heights.

FPIs pull out Rs 36,221 cr from markets in 13 days

FPIs pull out Rs 36,221 cr from markets in 13 days

Rediff.com13 Mar 2020

While a coordinated aggressive monetary easing from the central banks is most likely to offer some respite in the near-term, it is unlikely to improve the sentiments.

Unplanned vaccination can promote mutant strains: Experts to PM

Unplanned vaccination can promote mutant strains: Experts to PM

Rediff.com10 Jun 2021

A group of public health experts, including doctors from All India Institute of Medical Sciences and members from the national taskforce on COVID-19, have said that mass, indiscriminate and incomplete vaccination can trigger emergence of mutant strains and recommended that there is no need to inoculate those who had documented coronavirus infection.

A Last Christmas for Santha Bakery

A Last Christmas for Santha Bakery

Rediff.com27 Oct 2022

December 2022 could be the last Christmas for Santha Bakery, a business drawing its lineage from the first Christmas cake baked in Kerala.

Covid-19: With great power comes great responsibility

Covid-19: With great power comes great responsibility

Rediff.com18 Jul 2020

Cities are setting the rules that now carry life and death implications for their residents, and most of these rules are sought to be set by the municipal authorities who have never wielded such power, reports Subhomoy Bhattacharjee.

It's raining IPOs! 40-odd issues to mop up Rs 80K cr

It's raining IPOs! 40-odd issues to mop up Rs 80K cr

Rediff.com7 Jul 2021

The primary market is set for a bumper Rs 80,000-crore bonanza with 30 companies already filing IPO papers to raise Rs 55,000 crore, while around 10 more are lined up for this month itself, seeking to mop up another Rs 25,000 crore, say investment bankers. The market has been on a non-stop rally, hitting new records almost every week, on the back of an influx of investors -- a vast majority of them first-timers -- coupled with a flood of liquidity. Foreign funds alone had pumped in a record $35 billion into the market in FY21, while the trend has continued this fiscal as well. Domestic institutions led by LIC have also infused trillions of rupees, helping woo retail investors in troves -- the year saw over 20 million new investors coming to the market.

WFH: Lack of trust affects productivity

WFH: Lack of trust affects productivity

Rediff.com7 Jan 2021

'When people feel they are trusted, they invariably do their best, both as individuals and as a collective team.'

Banks' NPAs never went away, they were only hidden

Banks' NPAs never went away, they were only hidden

Rediff.com26 May 2022

Indeed, there were frauds, and the politician-banker-industrialist nexus played a role in the rise of NPAs, but governance issues in Indian banking are far more nuanced and complex, reveals Tamal Bandyopadhyay.

Zika virus cases in Rajasthan rise to 51

Zika virus cases in Rajasthan rise to 51

Rediff.com13 Oct 2018

The Zika virus has already been found in some mosquitoes taken as samples from Sindhi Camp while few mosquitoes collected from densely populated Shastri Nagar had already been found to be carriers of the virus leading to suspicion they are behind the spread of the infection.

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Rediff.com30 Sep 2021

In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.

Covid R-value climbing steadily in India; Kerala, NE states top list

Covid R-value climbing steadily in India; Kerala, NE states top list

Rediff.com29 Jul 2021

Among the metro cities, the R-values of Pune and Delhi are close to one, suggests an analysis by researchers at the Institute of Mathematical Sciences in Chennai.

'Coronavirus crisis is a wake-up call'

'Coronavirus crisis is a wake-up call'

Rediff.com27 Jun 2020

'You cannot fight a disease as complex as COVID-19 without a carefully calibrated, localised response.'

Amid rise in COVID-19 cases, govt says India better positioned

Amid rise in COVID-19 cases, govt says India better positioned

Rediff.com9 Jun 2020

The death toll due to the coronavirus infection rose to 7,466 and the cases mounted to 2,66,598 in the country.

India's COVID-19 recovery rate improves, fatality rate dips: Govt

India's COVID-19 recovery rate improves, fatality rate dips: Govt

Rediff.com1 Jun 2020

India is the seventh worst-hit nation by the COVID-19 pandemic in terms of the number of infections, after the US, Brazil, Russia, the UK, Spain and Italy. While the recovery rate in coronavirus infections is improving and has reached 48.19 per cent in India, there has been steady decline in the case fatality which is now 2.83 per cent, the health ministry said.

Where did Juhi Chawla go wrong?

Where did Juhi Chawla go wrong?

Rediff.com23 Jun 2021

Where Ms Chawla seems to have erred is that she has not been able to build the desired credibility required to champion the cause she took to court.

From Forest Hut To Top UK College

From Forest Hut To Top UK College

Rediff.com28 Sep 2021

Hercules Singh Munda's father used to open the gates to a forest. Today, Hercules leaves for London to open the gates of his many dreams.

Why India should talk about menstrual hygiene and safety

Why India should talk about menstrual hygiene and safety

Rediff.com7 Mar 2019

If we are able to provide safe, hygienic toilets, and affordable sanitary napkins, we could stop girls from dropping out of schools and help women feel more confident.

Chinese investors are suddenly in love with Indian startups

Chinese investors are suddenly in love with Indian startups

Rediff.com2 Jan 2020

Not just from the likes of Alibaba and Didi Chuxing, Indian startups saw a surge in Chinese funding from financial investors in 2019. This is a seven-fold jump from $459 million in 2016.

If all follow Covid behaviour, there won't be any 3rd wave: Govt

If all follow Covid behaviour, there won't be any 3rd wave: Govt

Rediff.com16 Jul 2021

Addressing a press conference, NITI Aayog Member (Health) Dr V K Paul said the question of the third wave keeps coming up because the population is still 'very vulnerable' to the infection.

Shortage of key chemical from US hits Covaxin ramp-up plans

Shortage of key chemical from US hits Covaxin ramp-up plans

Rediff.com22 Apr 2021

'In case of shortage of other raw material, like filters and bags, one can try to develop another vendor. However, for chemicals as critical as adjuvants, this is not possible'

Meet 23-yr-old Harshad Karkar, BMC's youngest corporator

Meet 23-yr-old Harshad Karkar, BMC's youngest corporator

Rediff.com24 Feb 2017

Sena gave ticket to Karkar when his father, a Sena corporator for the last 10 years, decided not to contest the polls this time.